- Home
- BCLI vs SSKN Comparison
BCLI vs SSKN Comparison
Compare BCLI & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- SSKN
- Stock Information
- Founded
- BCLI 2000
- SSKN 1989
- Country
- BCLI United States
- SSKN United States
- Employees
- BCLI N/A
- SSKN N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- SSKN Medical/Dental Instruments
- Sector
- BCLI Health Care
- SSKN Health Care
- Exchange
- BCLI Nasdaq
- SSKN Nasdaq
- Market Cap
- BCLI 9.9M
- SSKN 12.3M
- IPO Year
- BCLI N/A
- SSKN 2005
- Fundamental
- Price
- BCLI $1.73
- SSKN $2.70
- Analyst Decision
- BCLI Strong Buy
- SSKN
- Analyst Count
- BCLI 1
- SSKN 0
- Target Price
- BCLI $30.00
- SSKN N/A
- AVG Volume (30 Days)
- BCLI 41.1K
- SSKN 4.3K
- Earning Date
- BCLI 03-31-2025
- SSKN 03-26-2025
- Dividend Yield
- BCLI N/A
- SSKN N/A
- EPS Growth
- BCLI N/A
- SSKN N/A
- EPS
- BCLI N/A
- SSKN N/A
- Revenue
- BCLI N/A
- SSKN $32,674,999.00
- Revenue This Year
- BCLI N/A
- SSKN $0.94
- Revenue Next Year
- BCLI N/A
- SSKN $11.30
- P/E Ratio
- BCLI N/A
- SSKN N/A
- Revenue Growth
- BCLI N/A
- SSKN N/A
- 52 Week Low
- BCLI $1.05
- SSKN $2.51
- 52 Week High
- BCLI $11.85
- SSKN $6.00
- Technical
- Relative Strength Index (RSI)
- BCLI 40.62
- SSKN 43.38
- Support Level
- BCLI $1.69
- SSKN $2.65
- Resistance Level
- BCLI $1.93
- SSKN $2.89
- Average True Range (ATR)
- BCLI 0.11
- SSKN 0.13
- MACD
- BCLI -0.00
- SSKN 0.00
- Stochastic Oscillator
- BCLI 16.67
- SSKN 14.71
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.